Intrauterine Blood Transfusion: Current Indications and Associated Risks

被引：94

作者：

Lindenburg, Irene T. M. ^{[1
]}

van Kamp, Inge L. ^{[1
]}

Oepkes, Dick ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Obstet, NL-2300 RC Leiden, Netherlands

来源：

FETAL DIAGNOSIS AND THERAPY | 2014年 / 36卷 / 04期

关键词：

Alloimmunization; Chorioangioma; Fetal anemia; Fetomaternal hemorrhage; Intrauterine blood transfusion; Parvovirus B19; Perinatal outcome; Procedure-related complications; Sacrococcygeal teratoma; Twin-twin transfusion syndrome; RED-CELL ALLOIMMUNIZATION; MASSIVE FETOMATERNAL HEMORRHAGE; ANEMIA-POLYCYTHEMIA SEQUENCE; PARVOVIRUS B19 INFECTION; FETAL INTRAVASCULAR TRANSFUSION; HOMOZYGOUS ALPHA-THALASSEMIA; NONIMMUNE HYDROPS-FETALIS; PEAK SYSTOLIC VELOCITY; MIDDLE CEREBRAL-ARTERY; HEMOLYTIC-DISEASE;

D O I：

10.1159/000362812

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Fetal anemia is a serious complication in pregnancy and associated with perinatal mortality and morbidity. During 25 years of worldwide experience with intravascular c blood transfusion, a variety of indications have been described. Intrauterine transfusion (IUT) treatment is considered most successful for fetal anemia due to red cell alloimmunization. Moreover, the use of this procedure has also been reported in pregnancies with parvovirus B19 infection, fetomaternal hemorrhage and placental chorioangiomas, for example. This review focuses on the current indications of intrauterine blood transfusions. In addition, we describe the potential complications of IUT treatment. (C) 2014 S. Karger AG, Basel

引用

页码：263 / 271

页数：9

共 50 条

[1] TRANSFUSION OF BLOOD AND BLOOD SUBSTITUTES - INDICATIONS, CONTRAINDICATIONS AND RISKS
RUDOWSKI, W
[J]. ACTA MEDICA POLONA, 1981, 22 (02) : 161 - 180
[2] Current Risks in Blood Transfusion in Japan
Otsubo, Hiroko
Yamaguchi, Kazunari
[J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2008, 61 (06) : 427 - 433
[3] FETAL AND MATERNAL RISKS ASSOCIATED WITH INTRAUTERINE TRANSFUSION PROCEDURES
TURNER, JH
HUTCHINSON, DL
HAYASHI, TT
PETRICCIANI, JC
GERMANOWSKI, J
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1975, 123 (03) : 251 - 256
[4] Current indications for transfusion of erythrocytic blood components
Koloskov, AV
[J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2004, 49 (06): : 38 - 42
[5] THE RISKS ASSOCIATED WITH THE TRANSFUSION OF BLOOD AND BLOOD DERIVATIVES
SUGG, U
[J]. ANASTHESIOLOGIE & INTENSIVMEDIZIN, 1987, 28 (11): : 343 - 346
[6] Viral risks associated with blood transfusion
Sloand, EM
[J]. PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1997, 65 (03) : 428 - 431
[7] INDICATIONS FOR AND RISKS OF REPLACEMENT TRANSFUSION
NEWMAN, AJ
GROSS, S
[J]. PEDIATRICS, 1962, 29 (02) : 331 - &
[8] VIRAL RISKS ASSOCIATED TO BLOOD-TRANSFUSION
BARIN, F
[J]. REVUE FRANCAISE DE TRANSFUSION ET D HEMOBIOLOGIE, 1993, 36 (01): : 73 - 81
[9] Intrauterine blood transfusion
van Scheltema, P. N. Adama
Oepkes, D.
[J]. STATE OF THE ART PRESENTATIONS, 2010, 5 (01): : 1 - 6
[10] INTRAUTERINE BLOOD TRANSFUSION
Oepkes, D.
[J]. VOX SANGUINIS, 2010, 99 : 1 - 1

← 1 2 3 4 5 →